Cargando…
1083. Long-Term Prognosis of 448 Infectious Endocarditis Followed by an Endocarditis Team
BACKGROUND: The management of infective endocarditis (IE) by an expert medico-surgical team through multidisciplinary consultation meetings is now recommended. While it seems clear that it can improve the short-term prognosis of patients, long-term data are still scarce. METHODS: All patients hospit...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6254177/ http://dx.doi.org/10.1093/ofid/ofy210.918 |
_version_ | 1783373664660488192 |
---|---|
author | Camou, Fabrice Greib, Carine Machelart, Irène Dijos, Marina Cornolle, Claire Barandon, Laurent Peuchant, Olivia Wirth, Gaetane Issa, Nahema |
author_facet | Camou, Fabrice Greib, Carine Machelart, Irène Dijos, Marina Cornolle, Claire Barandon, Laurent Peuchant, Olivia Wirth, Gaetane Issa, Nahema |
author_sort | Camou, Fabrice |
collection | PubMed |
description | BACKGROUND: The management of infective endocarditis (IE) by an expert medico-surgical team through multidisciplinary consultation meetings is now recommended. While it seems clear that it can improve the short-term prognosis of patients, long-term data are still scarce. METHODS: All patients hospitalized between 2013 and 2017 in the three teaching hospitals of our center with an IE treated by the multidisciplinary team were followed prospectively at 1, 3, 6, and 12 months. The main objective was to determine the 1-year mortality of the entire cohort treated by the team. RESULTS: During the study, 493 patients had a certain or possible IE and the outcome at 1 year was known for 448 of them (4 lost to follow-up and 41 followed for less than 1 year): 254 had native valve IE (57%) and 194 had prosthetic valve IE (43%). The median age of IE patients was 69.3 years (155 patients were over 75 years old) and 329 (73%) were men. Healthcare-associated IE (HAIE) accounted for 47% of cases. A microorganism was isolated in 92% of cases (S. aureus = 24%), 252 patients (56%) had an embolic events and 68 (15%) had heart failure. The Charlson Median Comorbidity Index (ICC) was 5.0. Two hundred sixteen patients (48%) underwent surgery. The mortality rates at 1 month, 3 months, 6 months, and 1 year were, respectively, 14.1%, 19.0%, 23.2%, and 27.7%. The ICC at inclusion of patients who died at 1 year was 6.0 vs. 4.0 for survivors. Mortality at 1 year was significantly higher in case of HAIE (33% vs. 23%), documented S. aureus IE (39% vs. 24%), exclusive medical treatment (40% vs. 15%), and heart failure (43% vs. 25%). CONCLUSION: While the management of IE by an endocarditis team seems to improve the short-term prognosis of IE, 1-year mortality remains high as patients are increasingly older and have severe comorbidities. Our study confirms that early prognostic factors remain in the long term and that the prognosis is better in community-acquired IE with surgery. DISCLOSURES: All authors: No reported disclosures. |
format | Online Article Text |
id | pubmed-6254177 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | Oxford University Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-62541772018-11-28 1083. Long-Term Prognosis of 448 Infectious Endocarditis Followed by an Endocarditis Team Camou, Fabrice Greib, Carine Machelart, Irène Dijos, Marina Cornolle, Claire Barandon, Laurent Peuchant, Olivia Wirth, Gaetane Issa, Nahema Open Forum Infect Dis Abstracts BACKGROUND: The management of infective endocarditis (IE) by an expert medico-surgical team through multidisciplinary consultation meetings is now recommended. While it seems clear that it can improve the short-term prognosis of patients, long-term data are still scarce. METHODS: All patients hospitalized between 2013 and 2017 in the three teaching hospitals of our center with an IE treated by the multidisciplinary team were followed prospectively at 1, 3, 6, and 12 months. The main objective was to determine the 1-year mortality of the entire cohort treated by the team. RESULTS: During the study, 493 patients had a certain or possible IE and the outcome at 1 year was known for 448 of them (4 lost to follow-up and 41 followed for less than 1 year): 254 had native valve IE (57%) and 194 had prosthetic valve IE (43%). The median age of IE patients was 69.3 years (155 patients were over 75 years old) and 329 (73%) were men. Healthcare-associated IE (HAIE) accounted for 47% of cases. A microorganism was isolated in 92% of cases (S. aureus = 24%), 252 patients (56%) had an embolic events and 68 (15%) had heart failure. The Charlson Median Comorbidity Index (ICC) was 5.0. Two hundred sixteen patients (48%) underwent surgery. The mortality rates at 1 month, 3 months, 6 months, and 1 year were, respectively, 14.1%, 19.0%, 23.2%, and 27.7%. The ICC at inclusion of patients who died at 1 year was 6.0 vs. 4.0 for survivors. Mortality at 1 year was significantly higher in case of HAIE (33% vs. 23%), documented S. aureus IE (39% vs. 24%), exclusive medical treatment (40% vs. 15%), and heart failure (43% vs. 25%). CONCLUSION: While the management of IE by an endocarditis team seems to improve the short-term prognosis of IE, 1-year mortality remains high as patients are increasingly older and have severe comorbidities. Our study confirms that early prognostic factors remain in the long term and that the prognosis is better in community-acquired IE with surgery. DISCLOSURES: All authors: No reported disclosures. Oxford University Press 2018-11-26 /pmc/articles/PMC6254177/ http://dx.doi.org/10.1093/ofid/ofy210.918 Text en © The Author(s) 2018. Published by Oxford University Press on behalf of Infectious Diseases Society of America. http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited. For commercial re-use, please contact journals.permissions@oup.com |
spellingShingle | Abstracts Camou, Fabrice Greib, Carine Machelart, Irène Dijos, Marina Cornolle, Claire Barandon, Laurent Peuchant, Olivia Wirth, Gaetane Issa, Nahema 1083. Long-Term Prognosis of 448 Infectious Endocarditis Followed by an Endocarditis Team |
title | 1083. Long-Term Prognosis of 448 Infectious Endocarditis Followed by an Endocarditis Team |
title_full | 1083. Long-Term Prognosis of 448 Infectious Endocarditis Followed by an Endocarditis Team |
title_fullStr | 1083. Long-Term Prognosis of 448 Infectious Endocarditis Followed by an Endocarditis Team |
title_full_unstemmed | 1083. Long-Term Prognosis of 448 Infectious Endocarditis Followed by an Endocarditis Team |
title_short | 1083. Long-Term Prognosis of 448 Infectious Endocarditis Followed by an Endocarditis Team |
title_sort | 1083. long-term prognosis of 448 infectious endocarditis followed by an endocarditis team |
topic | Abstracts |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6254177/ http://dx.doi.org/10.1093/ofid/ofy210.918 |
work_keys_str_mv | AT camoufabrice 1083longtermprognosisof448infectiousendocarditisfollowedbyanendocarditisteam AT greibcarine 1083longtermprognosisof448infectiousendocarditisfollowedbyanendocarditisteam AT machelartirene 1083longtermprognosisof448infectiousendocarditisfollowedbyanendocarditisteam AT dijosmarina 1083longtermprognosisof448infectiousendocarditisfollowedbyanendocarditisteam AT cornolleclaire 1083longtermprognosisof448infectiousendocarditisfollowedbyanendocarditisteam AT barandonlaurent 1083longtermprognosisof448infectiousendocarditisfollowedbyanendocarditisteam AT peuchantolivia 1083longtermprognosisof448infectiousendocarditisfollowedbyanendocarditisteam AT wirthgaetane 1083longtermprognosisof448infectiousendocarditisfollowedbyanendocarditisteam AT issanahema 1083longtermprognosisof448infectiousendocarditisfollowedbyanendocarditisteam |